Richard F. Kefford

Richard F. Kefford

Level 6, 75 Talavera Road
Sydney, NSW 2019, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 164 publications

Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma.

Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma.

Journal: Oncogenesis
Published: April 10, 2026

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.

Journal: The Journal of investigative dermatology
Published: October 02, 2022

First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.

First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.

Journal: Investigational new drugs
Published: December 16, 2020

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Journal: Targeted oncology
Published: November 19, 2020

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.

Journal: Targeted oncology
Published: November 10, 2020

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma.

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma.

Journal: Cancers
Published: October 09, 2020

Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia.

Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia.

Journal: European journal of cancer (Oxford, England : 1990)
Published: July 30, 2020

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.

Journal: Cancers
Published: June 30, 2020

Clinicians' attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol.

Clinicians' attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol.

Journal: BMJ open
Published: March 25, 2020

Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B.

Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2020

Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature.

Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature.

Journal: Implementation science : IS
Published: December 10, 2019

Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors.

Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 02, 2019
Showing 1-12 of 164

Last Updated: 09/26/2026